Intra-abdominal candidiasis: it’s still a long way to get unquestionable data

Intensive Care Medicine

Volumn 41, Issue 9, 2015, Pages 1682-1684

  Montravers, Philippe ^a   Leroy, Olivier ^b   Eckmann, Christian ^c  

^a BICHAT HOSPITAL   (France)

^b Intensive Care Unit   (France)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ABDOMINAL ABSCESS; ABDOMINAL INFECTION; APACHE; CANDIDEMIA; CANDIDIASIS; EDITORIAL; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; INTESTINE PERFORATION; INTRAABDOMINAL CANDIDIASIS; MEDICAL HISTORY; MORBIDITY; MORTALITY; PATHOGENICITY; PERITONITIS; PRACTICE GUIDELINE; RISK FACTOR; SEPTIC SHOCK; FEMALE; MALE;

CANDIDIASIS; FEMALE; HUMANS; MALE;

EID: 84940449325     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-015-3894-y     Document Type: Editorial

References (14)

1. Leroy O, Gangneux JP, Montravers P, Mira JP, Gouin F, Sollet JP, Carlet J, Reynes J, Rosenheim M, Regnier B, Lortholary O (2009) Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005–2006). Crit Care Med 37(5):1612–1618. doi:10.1097/CCM.0b013e31819efac0
2. Dupont H, Paugam-Burtz C, Muller-Serieys C, Fierobe L, Chosidow D, Marmuse JP, Mantz J, Desmonts JM, Desmonts JM (2002) Predictive factors of mortality due to polymicrobial peritonitis with Candida isolation in peritoneal fluid in critically ill patients. Arch Surg 137(12):1341–1346
3. Montravers P, Dupont H, Gauzit R, Veber B, Auboyer C, Blin P, Hennequin C, Martin C (2006) Candida as a risk factor for mortality in peritonitis. Crit Care Med 34(3):646–652
4. Guery BP, Arendrup MC, Auzinger G, Azoulay E, Borges Sa M, Johnson EM, Muller E, Putensen C, Rotstein C, Sganga G, Venditti M, Zaragoza Crespo R, Kullberg BJ (2009) Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I epidemiology and diagnosis. Intensive Care Med 35(1):55–62. doi:10.1007/s00134-008-1338-7
5. Montravers P, Mira JP, Gangneux JP, Leroy O, Lortholary O (2011) A multicentre study of antifungal strategies and outcome of Candida spp. peritonitis in intensive-care units. Clin Microbiol Infect 17(7):1061–1067. doi:10.1111/j.1469-0691.2010.03360.x
6. Solomkin JS, Mazuski JE, Bradley JS, Rodvold KA, Goldstein EJ, Baron EJ, O’Neill PJ, Chow AW, Dellinger EP, Eachempati SR, Gorbach S, Hilfiker M, May AK, Nathens AB, Sawyer RG, Bartlett JG (2010) Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. Clin Infect Dis 50(2):133–164. doi:10.1086/649554
7. Bassetti M, Marchetti M, Chakrabarti A, Colizza S, Garnacho-Montero J, Kett DH, Munoz P, Cristini F, Andoniadou A, Viale P, Rocca GD, Roilides E, Sganga G, Walsh TJ, Tascini C, Tumbarello M, Menichetti F, Righi E, Eckmann C, Viscoli C, Shorr AF, Leroy O, Petrikos G, De Rosa FG (2013) A research agenda on the management of intra-abdominal candidiasis: results from a consensus of multinational experts. Intensive Care Med 39(12):2092–2106. doi:10.1007/s00134-013-3109-3
8. Bassetti M, Righi E, Ansaldi F, Merelli M, Scarparo C, Antonelli M, Garnacho-Montero J, Diaz-Martin A, Palacios-Garcia I, Luzzati R, Rosin C, Lagunes L, Rello J, Almirante B, Scotton PG, Baldin G, Dimopoulos G, Nucci M, Munoz P, Vena A, Bouza E, de Egea V, Colombo AL, Tascini C, Menichetti F, Tagliaferri E, Brugnaro P, Sanguinetti M, Mesini A, Sganga G, Viscoli C, Tumbarello M (2015) A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality. Intensive Care Med. doi:10.1007/s00134-015-3866-2
9. Bassetti M, Righi E, Ansaldi F, Merelli M, Trucchi C, De Pascale G, Diaz-Martin A, Luzzati R, Rosin C, Lagunes L, Trecarichi EM, Sanguinetti M, Posteraro B, Garnacho-Montero J, Sartor A, Rello J, Rocca GD, Antonelli M, Tumbarello M (2014) A multicenter study of septic shock due to candidemia: outcomes and predictors of mortality. Intensive Care Med 40(6):839–845. doi:10.1007/s00134-014-3310-z
10. Solomkin JS, Ristagno RL, Das AF, Cone JB, Wilson SE, Rotstein OD, Murphy BS, Severin KS, Bruss JB (2013) Source control review in clinical trials of anti-infective agents in complicated intra-abdominal infections. Clin Infect Dis 56(12):1765–1773. doi:10.1093/cid/cit128
11. Calandra T, Marchetti O (2004) Clinical trials of antifungal prophylaxis among patients undergoing surgery. Clin Infect Dis 39(Suppl 4):S185–S192. doi:10.1086/421955
12. Tissot F, Lamoth F, Hauser PM, Orasch C, Fluckiger U, Siegemund M, Zimmerli S, Calandra T, Bille J, Eggimann P, Marchetti O (2013) beta-glucan antigenemia anticipates diagnosis of blood culture-negative intraabdominal candidiasis. Am J Respir Crit Care Med 188(9):1100–1109. doi:10.1164/rccm.201211-2069OC
13. Leon C, Ruiz-Santana S, Saavedra P, Castro C, Ubeda A, Loza A, Martin-Mazuelos E, Blanco A, Jerez V, Ballus J, Alvarez-Rocha L, Utande-Vazquez A, Farinas O (2012) Value of beta-D-glucan and Candida albicans germ tube antibody for discriminating between Candida colonization and invasive candidiasis in patients with severe abdominal conditions. Intensive Care Med 38(8):1315–1325. doi:10.1007/s00134-012-2616-y
14. Eckmann C, Sanchez-Garcia M (2013) Monitoring treatment response in abdominal sepsis with procalcitonin–if only! Crit Care 17(6):1017. doi:10.1186/cc13154